Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0120
+0.0010 (9.09%)
Nov 11, 2026, 3:44 PM AEDT
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 46.36 million as of November 10, 2026. It is the 33,294th most valuable company in the world and the 789th biggest in Australia. Its market cap has increased by 129.48% in one year.
Market Cap
46.36M
Enterprise Value
39.98M
Revenue
737.30K
Global Rank
Country Rank
#789 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has increased from 39.36M to 46.36M, an increase of 17.81%. That is a compound annual growth rate of 0.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 46.36M | 40.24% |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 82.93M |
| Alterity Therapeutics | 68.73M |
| Prescient Therapeutics | 64.06M |
| Arovella Therapeutics | 60.44M |
| Entropy Neurodynamics | 47.37M |
| Neurizon Therapeutics | 46.51M |
| Amplia Therapeutics | 42.09M |
| Immutep | 38.32M |